MaxCyte Inc (NAS:MXCT)
$ 4.24 0.08 (1.92%) Market Cap: 432.15 Mil Enterprise Value: 293.28 Mil PE Ratio: 0 PB Ratio: 1.94 GF Score: 79/100

MaxCyte Inc at Proactive ONE2ONE Virtual Forum Transcript

Dec 02, 2021 / 06:00PM GMT
Release Date Price: $10.46 (+3.16%)
Doug Doerfler
MaxCyte, Inc. - President & CEO

Well, thank you, Sarah. It's great to be back with the Proactive team. The last time I was there, the shares were trading at abound a pound, so it's been quite a run for us. And thank you all for your support over the last year or so and hopefully everyone's been safe. So, as Sarah mentioned, we are a dual listed company on [AIM], and we just recently went public on the US Stock Exchange.

So, let me give you a little background, for those of you who are new to the story, about what MaxCyte is all about. So, this is a products business, so we manufacture -- we invented a technology which I'll talk about called flow electroporation. And we manufacture and ship and sell and license our technology through instruments and single use disposables.

And what we're doing is we're basically taking blood cells from a patient and we're engineering those blood cells -- or our partners are engineering those blood cells -- to turn those blood cells into a therapeutic to treat very serious diseases. This is a technology that is fearless and I'll talk a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot